## Key Hypothesis
Adversarial debate between specialist agents plus verifier consensus yields the most robust causal decisions.

## Implementation Delta
- Round 3: Debate-Consensus Scientist Ensemble integrated cross-agent feedback and updated evaluation controls.
- Added stronger intervention consistency tests on multi-omics and EHR alignment.

## Strengths
- Best robustness to domain shift with explicit disagreement resolution
- Improved reviewer-facing evidence packaging in round 3.

## Weaknesses
- Higher coordination overhead per iteration
- Computational cost remains non-trivial in challenging cohorts.

## Transferable Insights
- Verifier-gated consensus sharply cuts unsupported biomarker claims
- Structured peer summaries accelerate inter-worker learning without exposing private reports.

## Open Problems
- Need cost-aware pruning for low-impact debate branches
- Trade-off between robustness and runtime budget remains significant.

## Proposed Next Move
- Round 3 refinement for Debate-Consensus Scientist Ensemble: integrate top peer suggestions, tighten verifier checks, and reduce false negatives.
- Prioritize hypotheses that jointly reduce FNR and calibration error.
